Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of RGS19 in construction of lung squamous cell carcinoma prognosis prediction model as diagnostic marker

A diagnostic marker, RGS19 technology, applied in the field of biomedicine

Inactive Publication Date: 2021-06-08
JINSHAN HOSPITAL FUDAN UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] There is no report about the application of RGS19 of the present invention as a diagnostic marker in the construction of a prognosis prediction model for lung squamous cell carcinoma

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of RGS19 in construction of lung squamous cell carcinoma prognosis prediction model as diagnostic marker
  • Application of RGS19 in construction of lung squamous cell carcinoma prognosis prediction model as diagnostic marker
  • Application of RGS19 in construction of lung squamous cell carcinoma prognosis prediction model as diagnostic marker

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Example 1 Model construction and effect verification

[0025] 1. Method

[0026] 1.1 The training set comes from the RNA sequencing data and clinical data of 326 cases of lung squamous cell carcinoma from the TCGA database, and the expression profiles of autophagy-related genes (ARGs) are obtained. The validation set comes from the RNA sequencing data of 78 cases of lung squamous cell carcinoma from the GTO database. , to obtain all RNA expression profiles and autophagy-related gene (Autophagy-Related-Genes, ARGs) expression profiles.

[0027] 1.2 ARGs related to prognosis were screened out by survival analysis, and then the most critical survival-related ARGs (RGS19) were obtained by random forest method, and a risk prediction model based on this gene was constructed by deep machine learning method of random forest. The patients were divided into low-risk group and high-risk group according to the risk level obtained by the model. The model was validated by receiver ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of biomedicine and particularly relates to application of RGS19 in construction of a lung squamous cell carcinoma prognosis prediction model as a diagnostic marker. According to the application, the biomarker RGS19 is used through being combined with other clinical indexes, and lung squamous cell carcinoma prognosis detection can be made in an assisted manner; screening and constructing are carried out after carrying out full-transcriptome sequencing and machine learning based on lung squamous cell carcinoma specimens subjected to large-sample antitumor immunotherapy, and prognosis conditions of a lung squamous cell carcinoma sufferer can be efficiently and accurately predicted; and meanwhile, comprehensive evaluation on an immunization microenvironment of a tumor is achieved according to correlation between the risk of the tumor and different immunized cell infiltration levels, immunization-related channels and key immunization check point inhibitor expression levels, so that an effective instruction opinion is provided for clinicians for therapy decision making for the lung squamous cell carcinoma sufferer, occurrence of invalid therapy is reduced, and thus, the therapy cost and discomfort experience of the sufferer are reduced.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to the application of RGS19 as a diagnostic marker in constructing a prognosis prediction model of lung squamous cell carcinoma. Background technique [0002] Lung cancer is the most common cause of cancer-related death in the world today, and 80% of it is non-small cell lung cancer (NSCLC). The TNM staging is a generally accepted clinical staging system used to predict prognosis and guide the treatment of patients with non-small cell lung cancer. However, the current TNM staging system is far from sufficient to accurately predict the prognosis of patients with non-small cell lung cancer. For example, for lung cancer patients, even in clinical stage I, the recurrence rate of lung cancer is as high as 35-50%. In addition, a considerable number of patients can be cured by surgery alone, and these patients should be able to avoid the severe side effects of adjuvant chemotherapy b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6886A61K45/00A61P35/00
CPCC12Q1/6886A61K45/00A61P35/00C12Q2600/106C12Q2600/118C12Q2600/158
Inventor 罗露梦乔田奎武多娇庄喜兵
Owner JINSHAN HOSPITAL FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com